ITI Pharma and Healthcare Fund - Regular Plan - Growth Option

  • Scheme Category:  
  • Equity Scheme >  
  • Sectoral/Thematic Funds
NAV: ₹ 16.0304 ↓ -0.04%
[as on 5 December, 2025]

NAV chart with SMA (Simple moving average) overlay

SMA (Simple Moving Average)

  • 100 SMA
  • 200 SMA
  • 300 SMA
  • 400 SMA
  • 500 SMA

Returns

NameYTD1D1W1M3M1Y3Y5Y7Y10Y
ITI Pharma and Healthcare Fund - Regular Plan - Growth Option -8.57% -0.04% -0.97% -2.47% -1.16% -7.44% 18.33%---

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
98.31% 0.00% (Arbitrage: 0.00%) 0.00% 0.00% 1.69%

Equity

NameSymbol / ISINSectorWeight %QuantityQty change %
Sun Pharmaceutical Industries LimitedSUNPHARMA (INE044A01036)Pharmaceuticals & Biotechnology10.96%150888-
Divi's Laboratories LimitedDIVISLAB (INE361B01024)Pharmaceuticals & Biotechnology8.97%31001-
Apollo Hospitals Enterprise LimitedAPOLLOHOSP (INE437A01024)Healthcare Services6.35%19262+8.37%
Max Healthcare Institute LimitedMAXHEALTH (INE027H01010)Healthcare Services5.71%115755-
Torrent Pharmaceuticals LimitedTORNTPHARM (INE685A01028)Pharmaceuticals & Biotechnology4.51%29519+2.28%
Cohance Lifesciences LimitedCOHANCE (INE03QK01018)Pharmaceuticals & Biotechnology4.43%137055+5.20%
Fortis Healthcare LimitedFORTIS (INE061F01013)Healthcare Services3.98%90524-6.06%
Aurobindo Pharma LimitedAUROPHARMA (INE406A01037)Pharmaceuticals & Biotechnology3.70%75614-
Aster DM Healthcare LimitedASTERDM (INE914M01019)Healthcare Services3.62%124462-
Cipla LimitedCIPLA (INE059A01026)Pharmaceuticals & Biotechnology3.07%47677+43.27%
Lupin LimitedLUPIN (INE326A01037)Pharmaceuticals & Biotechnology3.04%36050-
Alkem Laboratories LimitedALKEM (INE540L01014)Pharmaceuticals & Biotechnology2.95%12453-
Neuland Laboratories LimitedNEULANDLAB (INE794A01010)Pharmaceuticals & Biotechnology2.82%3979-
Dr. Reddy's Laboratories LimitedDRREDDY (INE089A01031)Pharmaceuticals & Biotechnology2.57%49979+10.37%
Wockhardt LimitedWOCKPHARMA (INE049B01025)Pharmaceuticals & Biotechnology2.27%41176-
Abbott India LimitedABBOTINDIA (INE358A01014)Pharmaceuticals & Biotechnology2.20%1769+4.67%
Healthcare Global Enterprises LimitedHCG (INE075I01017)Healthcare Services1.77%55261-12.30%
Glenmark Pharmaceuticals LimitedGLENMARK (INE935A01035)Pharmaceuticals & Biotechnology1.73%21296+57.06%
Laurus Labs LimitedLAURUSLABS (INE947Q01028)Pharmaceuticals & Biotechnology1.69%41369+17.32%
Sai Life Sciences LimitedSAILIFE (INE570L01029)Pharmaceuticals & Biotechnology1.53%38836-14.60%
FDC LimitedFDC (INE258B01022)Pharmaceuticals & Biotechnology1.40%70933-
Sumitomo Chemical India LimitedSUMICHEM (INE258G01013)Fertilizers & Agrochemicals1.35%62461+3.78%
SBI Life Insurance Company LimitedSBILIFE (INE123W01016)Insurance1.25%14830-
IPCA Laboratories LimitedIPCALAB (INE571A01038)Pharmaceuticals & Biotechnology1.23%22488-
Mankind Pharma LimitedMANKIND (INE634S01028)Pharmaceuticals & Biotechnology1.22%11962-56.06%
Biocon LimitedBIOCON (INE376G01013)Pharmaceuticals & Biotechnology1.21%75706+70.96%
Onesource Specialty Pharma LimitedONESOURCE (INE013P01021)Pharmaceuticals & Biotechnology1.19%14989+19.65%
Rainbow Childrens Medicare LimitedRAINBOW (INE961O01016)Healthcare Services1.19%20150-
Orchid Pharma LimitedORCHPHARMA (INE191A01027)Pharmaceuticals & Biotechnology1.13%36258-
Piramal Pharma LimitedPPLPHARMA (INE0DK501011)Pharmaceuticals & Biotechnology1.13%131285+118.43%
Standard Glass Lining Technology LtdSGLTL (INE0M4D01010)Industrial Manufacturing1.05%133598-
GlaxoSmithKline Pharmaceuticals LimitedGLAXO (INE159A01016)Pharmaceuticals & Biotechnology0.99%8765+10.87%
Poly Medicure LimitedPOLYMED (INE205C01021)Healthcare Equipment & Supplies0.93%10779-
Caplin Point Laboratories LimitedCAPLIPOINT (INE475E01026)Pharmaceuticals & Biotechnology0.86%9867-
Supriya Lifescience LimitedSUPRIYA (INE07RO01027)Pharmaceuticals & Biotechnology0.85%25370-23.87%
Linde India LimitedLINDEINDIA (INE473A01011)Chemicals & Petrochemicals0.81%3135-
Shilpa Medicare LimitedSHILPAMED (INE790G01031)Pharmaceuticals & Biotechnology0.75%49568-
UPL LimitedUPL (INE628A01036)Fertilizers & Agrochemicals0.72%23209-
Zydus Lifesciences LimitedZYDUSLIFE (INE010B01027)Pharmaceuticals & Biotechnology0.70%16792+16.22%
Syngene International LimitedSYNGENE (INE398R01022)Healthcare Services0.48%17159-

Debt

NameRatingWeight %
Portfolio data is as on date 31 October, 2025

NAV (Net asset value) history

ITI Pharma and Healthcare Fund - Regular Plan - Growth Option - 30 days NAV history

DateNAV
5 December, 202516.0304
4 December, 202516.0366
3 December, 202516.0155
2 December, 202516.0757
1 December, 202516.1094
28 November, 202516.1874
27 November, 202516.1597
26 November, 202516.1903
25 November, 202516.0386
24 November, 202515.9867
21 November, 202516.0723
20 November, 202516.1665
19 November, 202516.1935
18 November, 202516.1768
17 November, 202516.3102
14 November, 202516.2480
13 November, 202516.2282
12 November, 202516.3106
11 November, 202516.2089
10 November, 202516.2869
7 November, 202516.2591
6 November, 202516.3286
4 November, 202516.4369
3 November, 202516.4914
31 October, 202516.3029
30 October, 202516.4101
29 October, 202516.4408
28 October, 202516.3841
27 October, 202516.3838
24 October, 202516.4682

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option?
    The latest NAV of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option is 16.0304 as on 5 December, 2025.
  • What are YTD (year to date) returns of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option?
    The YTD (year to date) returns of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option are -8.57% as on 5 December, 2025.
  • What are 1 year returns of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option?
    The 1 year returns of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option are -7.44% as on 5 December, 2025.
  • What are 3 year CAGR returns of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option?
    The 3 year annualized returns (CAGR) of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option are 18.33% as on 5 December, 2025.